Intra-Cellular Therapies Market Cap

DSE:STANCERAM has a market cap or net worth of 531.71 million as of August 12, 2025. Its market cap has decreased by -16.11% in one year.

Market Cap

531.71M

Enterprise Value

759.54M

Revenue

-536.58K

Ranking

n/a

PE Ratio

n/a

Stock Price

$82.30

Market Cap Chart

Since December 20, 2004, DSE:STANCERAM's market cap has increased from 87.90M to 531.71M, an increase of 504.91%. That is a compound annual growth rate of 9.11%.

Market Cap History

Date	Market Cap	% Change
Aug 11, 2025	531.71M	17.57%
Dec 30, 2024	452.25M	-52.99%
Dec 28, 2023	961.99M	5.08%
Dec 29, 2022	915.47M	-10.32%
Dec 30, 2021	1.02B	-48.68%
Dec 30, 2020	1.99B	-54.41%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 27, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Grameenphone	426.96B
Square Pharmaceuticals PLC.	199.98B
British American Tobacco Bangladesh Company	158.98B
Robi Axiata PLC.	142.47B
Walton Hi-Tech Industries	135.56B
BRAC Bank PLC.	133.39B
Bangladesh Export Import Company	103.85B
Marico Bangladesh	90.58B

Market Cap Rankings